The researchers found that 13.9 percent of 158,849 eligible patients with heart failure and an LVEF >40 percent were prescribed an SGLT2i at hospital discharge. There was an increase in quarterly ...

to investigate the tolerability of two of the most widely used beta-blockers in elderly heart failure patients with impaired and preserved LVEF. This is the first randomized, double-blind trial to ...